VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
63,479
AK1,562
AL4,914
AR3,110
AS44
AZ12,730
CA54,886
CO10,464
CT7,347
DC1,568
DE1,561
FL33,514
FM3
GA12,508
GU74
HI2,078
IA4,130
ID2,361
IL18,091
IN22,023
KS4,061
KY6,276
LA4,395
MA13,121
MD11,272
ME2,858
MH8
MI16,697
MN10,689
MO8,360
MP30
MS2,487
MT2,035
NC14,437
ND1,184
NE2,562
NH2,717
NJ16,033
NM3,532
NV3,784
NY30,921
OH17,029
OK5,673
OR7,479
PA21,111
PR1,959
QM2
RI1,833
SC5,601
SD1,087
TN8,048
TX31,896
UT3,791
VA13,180
VI48
VT1,592
WA13,026
WI9,856
WV2,120
WY754
XB5
XL1
XV2

ID: 1596416
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History Information was provided. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VERTIGO (vertigo). The patient was treated with PENICILLIN NOS for Vertigo, at an unspecified dose and frequency. At the time of the report, VERTIGO (vertigo) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant Concomitant medications were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Mar-2021 and was forwarded to Moderna on 04-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History Information was provided. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VERTIGO (vertigo). The patient was treated with PENICILLIN NOS for Vertigo, at an unspecified dose and frequency. At the time of the report, VERTIGO (vertigo) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant Concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1596417
Sex: F
Age:
State:

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness all over her body) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No Medical History information was reported. In March 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced PRURITUS (Itchiness all over her body). At the time of the report, PRURITUS (Itchiness all over her body) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1596418
Sex: F
Age:
State: PA

Vax Date: 03/02/2021
Onset Date: 03/03/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (Rash around the injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. No Medical History information was reported. On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced INJECTION SITE RASH (Rash around the injection site). At the time of the report, INJECTION SITE RASH (Rash around the injection site) outcome was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1596419
Sex: M
Age:
State: CA

Vax Date: 03/05/2021
Onset Date: 03/06/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: muscle pull; sore in shoulder; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (muscle pull) and ARTHRALGIA (sore in shoulder) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. Concomitant products included METHYLPREDNISOLONE, LOSARTAN, METOPROLOL, WARFARIN and ROSUVASTATIN for an unknown indication. On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 06-Mar-2021, the patient experienced MUSCLE SPASMS (muscle pull) and ARTHRALGIA (sore in shoulder). At the time of the report, MUSCLE SPASMS (muscle pull) and ARTHRALGIA (sore in shoulder) outcome was unknown. Treatment details included Methylprednisolone.

Other Meds: METHYLPREDNISOLONE; LOSARTAN; METOPROLOL; WARFARIN; ROSUVASTATIN

Current Illness:

ID: 1596420
Sex: F
Age: 77
State: MA

Vax Date: 03/03/2021
Onset Date: 03/04/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: flu like symptoms and side effects; every joint in her body ached like she couldn't describe; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms and side effects) and MYALGIA (every joint in her body ached like she couldn't describe) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history was provided.). On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms and side effects) and MYALGIA (every joint in her body ached like she couldn't describe). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms and side effects) and MYALGIA (every joint in her body ached like she couldn't describe) outcome was unknown. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1596421
Sex: F
Age: 72
State:

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swelling at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (Swelling at the site of injection) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced INJECTION SITE SWELLING (Swelling at the site of injection). At the time of the report, INJECTION SITE SWELLING (Swelling at the site of injection) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment and Concomitant medicines were not included Action taken with mRNA-1273 in response to the event was unknown

Other Meds:

Current Illness:

ID: 1596422
Sex: F
Age: 55
State: MO

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Warmth; Dizziness; Redness; Pain; Swelling; Headache; Fatigue; Chills; Fever (Temperature 102 to 104F); This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (Warmth), DIZZINESS (Dizziness), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE PAIN (Pain) and VACCINATION SITE SWELLING (Swelling) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history information was reported. Concomitant products included ASCORBIC ACID (VIT C), LISINOPRIL, CHLORTHALIDONE, CLOPIDOGREL, ASPIRIN [ACETYLSALICYLIC ACID], CETIRIZINE, METOPROLOL, ATORVASTATIN and MONTELUKAST for an unknown indication. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warmth), DIZZINESS (Dizziness), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE PAIN (Pain), VACCINATION SITE SWELLING (Swelling), HEADACHE (Headache), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever (Temperature 102 to 104F)). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. On 04-Mar-2021, HEADACHE (Headache), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever (Temperature 102 to 104F)) had resolved. At the time of the report, VACCINATION SITE WARMTH (Warmth), DIZZINESS (Dizziness), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE PAIN (Pain) and VACCINATION SITE SWELLING (Swelling) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Mar-2021, Body temperature: 102 - 104f (High) Temperature 102 to 104F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown), the reporter did not provide any causality assessments.

Other Meds: VIT C; LISINOPRIL; CHLORTHALIDONE; CLOPIDOGREL; ASPIRIN [ACETYLSALICYLIC ACID]; CETIRIZINE; METOPROLOL; ATORVASTATIN; MONTELUKAST

Current Illness:

ID: 1596423
Sex: F
Age:
State: OH

Vax Date: 02/24/2021
Onset Date: 03/06/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Redness on her left arm, and other parts of her body; Itchiness on her left arm; Pain at the injection site; Tenderness at the injection site; Inflammation at the injection site; This spontaneous case was reported by a nurse and describes the occurrence of ERYTHEMA (Redness on her left arm, and other parts of her body), PRURITUS (Itchiness on her left arm), INJECTION SITE PAIN (Pain at the injection site), TENDERNESS (Tenderness at the injection site) and INJECTION SITE INFLAMMATION (Inflammation at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. No Medical History information was reported. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced ERYTHEMA (Redness on her left arm, and other parts of her body), PRURITUS (Itchiness on her left arm), INJECTION SITE PAIN (Pain at the injection site), TENDERNESS (Tenderness at the injection site) and INJECTION SITE INFLAMMATION (Inflammation at the injection site). At the time of the report, ERYTHEMA (Redness on her left arm, and other parts of her body), PRURITUS (Itchiness on her left arm), INJECTION SITE PAIN (Pain at the injection site), TENDERNESS (Tenderness at the injection site) and INJECTION SITE INFLAMMATION (Inflammation at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment and concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1596424
Sex: M
Age:
State:

Vax Date: 03/05/2021
Onset Date: 03/05/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. No Medical History information was reported. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication was provided. No treatment details were provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1596425
Sex: M
Age: 88
State: NY

Vax Date: 01/22/2021
Onset Date: 02/27/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: shaking all over; breathing really hard; nauseated; dry heaves; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shaking all over), DYSPNOEA (breathing really hard), NAUSEA (nauseated) and RETCHING (dry heaves) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 016M20A) for COVID-19 vaccination. The patient's past medical history included Alzheimer's disease. Concomitant products included CLOPIDOGREL, GALANTAMINE and ROSUVASTATIN. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced TREMOR (shaking all over), DYSPNOEA (breathing really hard), NAUSEA (nauseated) and RETCHING (dry heaves). On 28-Feb-2021, TREMOR (shaking all over), DYSPNOEA (breathing really hard), NAUSEA (nauseated) and RETCHING (dry heaves) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment details were provided. Reporter did not allow further contact

Other Meds: CLOPIDOGREL; GALANTAMINE; ROSUVASTATIN

Current Illness:

ID: 1596426
Sex: F
Age: 55
State: FL

Vax Date: 01/12/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itching in her body, as if a mosquito was biting her in various parts of her body; itch, as if she has an allergy clothing; uncomfortable; little arm pain; chills; blood pressure goes up because she gets nervous; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching in her body, as if a mosquito was biting her in various parts of her body), PRURITUS (itch, as if she has an allergy clothing), DISCOMFORT (uncomfortable), PAIN IN EXTREMITY (little arm pain) and CHILLS (chills) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. Concomitant products included blood pressure amlodipine, hydrochlorothiazide Diuretic, aspirin per day and ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (itching in her body, as if a mosquito was biting her in various parts of her body), PRURITUS (itch, as if she has an allergy clothing), DISCOMFORT (uncomfortable), PAIN IN EXTREMITY (little arm pain), CHILLS (chills) and HYPERTENSION (blood pressure goes up because she gets nervous). At the time of the report, PRURITUS (itching in her body, as if a mosquito was biting her in various parts of her body), PRURITUS (itch, as if she has an allergy clothing), DISCOMFORT (uncomfortable), PAIN IN EXTREMITY (little arm pain), CHILLS (chills) and HYPERTENSION (blood pressure goes up because she gets nervous) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Reporter did not allow further contact

Other Meds: blood pressure amlodipine; hydrochlorothiazide Diuretic; aspirin per day; VITAMINS A & D

Current Illness:

ID: 1596427
Sex: F
Age: 66
State: WI

Vax Date: 02/17/2021
Onset Date: 02/17/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash; Muscle soreness; Red patch; Red marks; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash), MYALGIA (Muscle soreness), RASH ERYTHEMATOUS (Red patch) and ERYTHEMA (Red marks) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history). On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash), MYALGIA (Muscle soreness), RASH ERYTHEMATOUS (Red patch) and ERYTHEMA (Red marks). At the time of the report, VACCINATION SITE RASH (Rash), MYALGIA (Muscle soreness), RASH ERYTHEMATOUS (Red patch) and ERYTHEMA (Red marks) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication was provided. No treatment details were provided.

Other Meds:

Current Illness:

ID: 1596428
Sex: F
Age:
State:

Vax Date: 03/02/2021
Onset Date: 03/03/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: still have swollen area at the injection site; slight headache; place where she gave me vaccine was swollen; A spontaneous report (United States) was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events slight headache, place where she gave me vaccine was swollen, still have swollen area at the injection site. The patient's medical history was not provided. No relevant concomitant medications were reported. On 2 Mar 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Lot# 025A21A) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 3 Mar 2021, the patient experienced the event(s) slight headache. place where she gave me vaccine was swollen. On 5 Mar 2021, the patient experienced the event(s) still have swollen area at the injection site. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event(s), slight headache, place where she gave me vaccine was swollen,still have swollen area at the injection site was unknown.

Other Meds:

Current Illness:

ID: 1596429
Sex: M
Age: 83
State: MA

Vax Date: 02/18/2021
Onset Date: 03/04/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itching around belly; Rash around belly; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching around belly) and RASH (Rash around belly) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O24M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PRURITUS (Itching around belly) and RASH (Rash around belly). At the time of the report, PRURITUS (Itching around belly) and RASH (Rash around belly) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was provided. No treatment details were provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1596430
Sex: F
Age: 78
State: OH

Vax Date: 03/04/2021
Onset Date: 03/04/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: no appetite; flu like symptoms; feels like has been hit by a truck; Fever; terrific headache; Injection arm pain; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (no appetite), INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING ABNORMAL (feels like has been hit by a truck), PYREXIA (Fever) and HEADACHE (terrific headache) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE PAIN (Injection arm pain). On 05-Mar-2021, the patient experienced DECREASED APPETITE (no appetite), INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING ABNORMAL (feels like has been hit by a truck), PYREXIA (Fever) and HEADACHE (terrific headache). At the time of the report, DECREASED APPETITE (no appetite), INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING ABNORMAL (feels like has been hit by a truck), PYREXIA (Fever), HEADACHE (terrific headache) and VACCINATION SITE PAIN (Injection arm pain) outcome was unknown. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1596431
Sex: M
Age: 18
State: PA

Vax Date: 03/04/2021
Onset Date: 03/05/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dizziness; Sore Arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore Arm) and HEADACHE (headache) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore Arm) and HEADACHE (headache). At the time of the report, DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore Arm) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was provided. No treatment details were provided.

Other Meds:

Current Illness:

ID: 1596432
Sex: F
Age: 41
State: IN

Vax Date: 03/06/2021
Onset Date: 03/07/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sick to her stomach; difficulty breathing; HOT; nauseous; everything hurt (muscle pain); headache; chills; low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (sick to her stomach), DYSPNOEA (difficulty breathing), FEELING HOT (HOT), NAUSEA (nauseous) and MYALGIA (everything hurt (muscle pain)) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Asthma and Allergy NOS. Concomitant products included ALBUTEROL [SALBUTAMOL] for an unknown indication. On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (sick to her stomach), DYSPNOEA (difficulty breathing), FEELING HOT (HOT), NAUSEA (nauseous), MYALGIA (everything hurt (muscle pain)), HEADACHE (headache), CHILLS (chills) and PYREXIA (low grade fever). At the time of the report, ABDOMINAL DISCOMFORT (sick to her stomach), DYSPNOEA (difficulty breathing), FEELING HOT (HOT), NAUSEA (nauseous), MYALGIA (everything hurt (muscle pain)), HEADACHE (headache), CHILLS (chills) and PYREXIA (low grade fever) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. No treatment information was provided.

Other Meds: ALBUTEROL [SALBUTAMOL]

Current Illness: Allergy NOS; Asthma

ID: 1596433
Sex: F
Age: 76
State: TX

Vax Date: 02/24/2021
Onset Date: 03/03/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: dark pink discoloration at the site of injection; heat at the site of injection; itchiness at the site of injection; slight pain at the site of injection; sense of slight fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (dark pink discoloration at the site of injection), VACCINATION SITE WARMTH (heat at the site of injection), VACCINATION SITE PRURITUS (itchiness at the site of injection), VACCINATION SITE PAIN (slight pain at the site of injection) and FATIGUE (sense of slight fatigue) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. No medical history was reported. Concomitant products included LOSARTAN for an unknown indication. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (dark pink discoloration at the site of injection), VACCINATION SITE WARMTH (heat at the site of injection), VACCINATION SITE PRURITUS (itchiness at the site of injection), VACCINATION SITE PAIN (slight pain at the site of injection) and FATIGUE (sense of slight fatigue). At the time of the report, VACCINATION SITE ERYTHEMA (dark pink discoloration at the site of injection), VACCINATION SITE WARMTH (heat at the site of injection), VACCINATION SITE PRURITUS (itchiness at the site of injection), VACCINATION SITE PAIN (slight pain at the site of injection) and FATIGUE (sense of slight fatigue) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment information was not reported.

Other Meds: LOSARTAN

Current Illness:

ID: 1596434
Sex: F
Age:
State:

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Body ache; chills; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body ache) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced MYALGIA (Body ache) and CHILLS (chills). At the time of the report, MYALGIA (Body ache) and CHILLS (chills) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. No Concomitant medications were reported No treatment medications were reported Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow-up information received on 21-Jul-2021 and included events outcome was updated from unknown to recovered.

Other Meds:

Current Illness:

ID: 1596435
Sex: F
Age:
State: IN

Vax Date: 02/13/2021
Onset Date: 03/01/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: flu like symptoms; peeing terribly; body aches; bad fatigue that she hardly get up; This spontaneous case was reported by an other health care professional and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), POLLAKIURIA (peeing terribly), MYALGIA (body aches) and FATIGUE (bad fatigue that she hardly get up) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included METHOTREXATE, FOLIC ACID and AMLODIPINE for an unknown indication. On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), POLLAKIURIA (peeing terribly), MYALGIA (body aches) and FATIGUE (bad fatigue that she hardly get up). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), POLLAKIURIA (peeing terribly), MYALGIA (body aches) and FATIGUE (bad fatigue that she hardly get up) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds: METHOTREXATE; FOLIC ACID; AMLODIPINE

Current Illness:

ID: 1596436
Sex: F
Age: 34
State: LA

Vax Date: 02/27/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: body aches; Covid arm; stomach ache; redness on arm; fever; pain in injection site; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), VACCINATION SITE REACTION (Covid arm), ABDOMINAL PAIN UPPER (stomach ache), VACCINATION SITE ERYTHEMA (redness on arm) and PYREXIA (fever) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (body aches), VACCINATION SITE REACTION (Covid arm), ABDOMINAL PAIN UPPER (stomach ache), VACCINATION SITE ERYTHEMA (redness on arm), PYREXIA (fever), VACCINATION SITE PAIN (pain in injection site) and HEADACHE (headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, PAIN (body aches), VACCINATION SITE REACTION (Covid arm), ABDOMINAL PAIN UPPER (stomach ache), VACCINATION SITE ERYTHEMA (redness on arm), PYREXIA (fever), VACCINATION SITE PAIN (pain in injection site) and HEADACHE (headache) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No Concomitant medications were provided

Other Meds:

Current Illness:

ID: 1596437
Sex: F
Age: 65
State: OH

Vax Date: 03/01/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1596438
Sex: F
Age: 50
State: CA

Vax Date: 03/05/2021
Onset Date: 03/05/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: cold sore; sore arm; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ORAL HERPES (cold sore), PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization. The patient's past medical history included No adverse event. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 05-Mar-2021, the patient experienced ORAL HERPES (cold sore), PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue). At the time of the report, ORAL HERPES (cold sore) and PAIN IN EXTREMITY (sore arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1596439
Sex: F
Age: 64
State: CA

Vax Date: 03/04/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm Soreness; Flu-like symptoms; No energy; Nausea; Muscle Aches; Very bad fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm Soreness), INFLUENZA LIKE ILLNESS (Flu-like symptoms), ASTHENIA (No energy), NAUSEA (Nausea) and MYALGIA (Muscle Aches) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm Soreness), INFLUENZA LIKE ILLNESS (Flu-like symptoms), ASTHENIA (No energy), NAUSEA (Nausea), MYALGIA (Muscle Aches) and FATIGUE (Very bad fatigue). At the time of the report, PAIN IN EXTREMITY (Arm Soreness), INFLUENZA LIKE ILLNESS (Flu-like symptoms), ASTHENIA (No energy), NAUSEA (Nausea), MYALGIA (Muscle Aches) and FATIGUE (Very bad fatigue) outcome was unknown.

Other Meds:

Current Illness:

ID: 1596440
Sex: F
Age:
State: MI

Vax Date:
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm; little bit nausea; extreme fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), NAUSEA (little bit nausea) and FATIGUE (extreme fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concurrent medical conditions included Asthma. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), NAUSEA (little bit nausea) and FATIGUE (extreme fatigue). At the time of the report, PAIN IN EXTREMITY (sore arm), NAUSEA (little bit nausea) and FATIGUE (extreme fatigue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness: Asthma

ID: 1596441
Sex: F
Age:
State: FL

Vax Date: 03/05/2021
Onset Date: 03/05/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itchy around the injection site; red circle around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy around the injection site) and VACCINATION SITE ERYTHEMA (red circle around the injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. No Medical History information was reported. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchy around the injection site) and VACCINATION SITE ERYTHEMA (red circle around the injection site). At the time of the report, VACCINATION SITE PRURITUS (itchy around the injection site) and VACCINATION SITE ERYTHEMA (red circle around the injection site) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: No specific follow-up information recorded.

Other Meds:

Current Illness:

ID: 1596442
Sex: F
Age: 70
State: CA

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and CHILLS (chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PYREXIA (fever) and CHILLS (chills). At the time of the report, PYREXIA (fever) and CHILLS (chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided. No relevant concomitant medications reported.

Other Meds:

Current Illness:

ID: 1596443
Sex: F
Age: 89
State: FL

Vax Date: 03/02/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swollen arm; warm to touch at the injection site; hardness at the injection site; redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm), VACCINATION SITE WARMTH (warm to touch at the injection site), VACCINATION SITE INDURATION (hardness at the injection site) and VACCINATION SITE ERYTHEMA (redness at the injection site) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included PARACETAMOL (TYLENOL) and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (swollen arm), VACCINATION SITE WARMTH (warm to touch at the injection site), VACCINATION SITE INDURATION (hardness at the injection site) and VACCINATION SITE ERYTHEMA (redness at the injection site). At the time of the report, PERIPHERAL SWELLING (swollen arm), VACCINATION SITE WARMTH (warm to touch at the injection site), VACCINATION SITE INDURATION (hardness at the injection site) and VACCINATION SITE ERYTHEMA (redness at the injection site) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds: TYLENOL; SYNTHROID

Current Illness:

ID: 1596444
Sex: F
Age: 58
State: GA

Vax Date: 03/04/2021
Onset Date: 03/04/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: My left wrist is hurting, and it gives out; On my right side, I am having really sharp pains; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (My left wrist is hurting, and it gives out) and PAIN (On my right side, I am having really sharp pains) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The patient's past medical history included High cholesterol (Patient was taking cholesterol medication) since an unknown date. Concomitant products included VITAMIN E NOS, FISH OIL, GARLIC [ALLIUM SATIVUM] and METOPROLOL TARTRATE for an unknown indication. On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced ARTHRALGIA (My left wrist is hurting, and it gives out) and PAIN (On my right side, I am having really sharp pains). At the time of the report, ARTHRALGIA (My left wrist is hurting, and it gives out) and PAIN (On my right side, I am having really sharp pains) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication also included unspecified cholesterol medication. The patient did not receive any treatment medication 3-5 hours after the vaccine the symptoms started. Her left wrist is hurting, when she picks something up, it gives up and she drops whatever she is holding. It goes on and off. On her right side, she was having really sharp pains, every 30 min-1 hours.

Other Meds: VITAMIN E NOS; FISH OIL; GARLIC [ALLIUM SATIVUM]; METOPROLOL TARTRATE

Current Illness: High cholesterol (Patient was taking cholesterol medication)

ID: 1596445
Sex: F
Age: 66
State: FL

Vax Date: 02/28/2021
Onset Date: 03/01/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swelling Injection Site; Sore Injection Site; Armpit is Sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling Injection Site), VACCINATION SITE PAIN (Sore Injection Site) and AXILLARY PAIN (Armpit is Sore) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Swelling Injection Site), VACCINATION SITE PAIN (Sore Injection Site) and AXILLARY PAIN (Armpit is Sore). At the time of the report, VACCINATION SITE SWELLING (Swelling Injection Site), VACCINATION SITE PAIN (Sore Injection Site) and AXILLARY PAIN (Armpit is Sore) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided. No relevant concomitant medications reported.

Other Meds:

Current Illness:

ID: 1596446
Sex: F
Age:
State:

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 28-Feb-2021, PAIN IN EXTREMITY (sore arm) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment information was provided. No relevant concomitant medications reported. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1596447
Sex: F
Age: 37
State: MA

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swollen lymph nodes at the arm; Stopped menstrual cycle; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE LYMPHADENOPATHY (swollen lymph nodes at the arm) and AMENORRHOEA (Stopped menstrual cycle) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012C26A) for COVID-19 vaccination. No Medical History information was reported. On 15-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE LYMPHADENOPATHY (swollen lymph nodes at the arm) and AMENORRHOEA (Stopped menstrual cycle). At the time of the report, VACCINATION SITE LYMPHADENOPATHY (swollen lymph nodes at the arm) was resolving and AMENORRHOEA (Stopped menstrual cycle) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided. No relevant concomitant medications reported.

Other Meds:

Current Illness:

ID: 1596448
Sex: F
Age: 64
State: MI

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Delayed itchy rash; Fever that went awat overnight; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Delayed itchy rash) and PYREXIA (Fever that went awat overnight) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PYREXIA (Fever that went awat overnight). On 28-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Delayed itchy rash). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Itchy, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (Delayed itchy rash) had not resolved and PYREXIA (Fever that went awat overnight) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: not provided results not provided. She had a covid 19 test that came back a week earlier. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by reporter.

Other Meds:

Current Illness:

ID: 1596449
Sex: F
Age:
State: SC

Vax Date: 03/04/2021
Onset Date: 03/05/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm is hurting a lot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm is hurting a lot) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. No Medical History information was reported. On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm is hurting a lot). At the time of the report, PAIN IN EXTREMITY (arm is hurting a lot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was reported. No treatment medication was reported.

Other Meds:

Current Illness:

ID: 1596450
Sex: F
Age: 84
State: CA

Vax Date: 02/04/2021
Onset Date: 03/04/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; Soreness at the injection site; Fatigue; A little nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), VACCINATION SITE PAIN (Soreness at the injection site), FATIGUE (Fatigue) and NAUSEA (A little nausea) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 013M20A) for COVID-19 vaccination. No Medical History information was reported. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced HEADACHE (Headache), VACCINATION SITE PAIN (Soreness at the injection site), FATIGUE (Fatigue) and NAUSEA (A little nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEADACHE (Headache), VACCINATION SITE PAIN (Soreness at the injection site), FATIGUE (Fatigue) and NAUSEA (A little nausea) had not resolved. No concomitant medications were provided.

Other Meds:

Current Illness:

ID: 1596451
Sex: M
Age: 70
State: TX

Vax Date: 03/04/2021
Onset Date: 03/05/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm; Slight headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and HEADACHE (Slight headache) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and HEADACHE (Slight headache). At the time of the report, PAIN IN EXTREMITY (Sore arm) and HEADACHE (Slight headache) had resolved. No treatment information was provided. No relevant concomitant medications reported.

Other Meds:

Current Illness:

ID: 1596452
Sex: M
Age: 46
State: CA

Vax Date: 03/01/2021
Onset Date: 03/05/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: low-grade fever 99F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (low-grade fever 99F) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced PYREXIA (low-grade fever 99F). At the time of the report, PYREXIA (low-grade fever 99F) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Body temperature: 99 (Borderline) 99 F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1596453
Sex: F
Age: 66
State: LA

Vax Date: 02/19/2021
Onset Date: 03/03/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: big red rash on the injection arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (big red rash on the injection arm) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. No Medical History information was reported. On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced RASH ERYTHEMATOUS (big red rash on the injection arm). At the time of the report, RASH ERYTHEMATOUS (big red rash on the injection arm) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment information provided.

Other Meds:

Current Illness:

ID: 1596454
Sex: U
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: shingles; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles). At the time of the report, HERPES ZOSTER (shingles) outcome was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not Applicable.

Other Meds:

Current Illness:

ID: 1596455
Sex: F
Age: 62
State: MD

Vax Date: 02/02/2021
Onset Date: 03/03/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: cough; sore throat; Flu; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), OROPHARYNGEAL PAIN (sore throat) and INFLUENZA (Flu) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030m20a) for COVID-19 vaccination. Concomitant products included GABAPENTIN for an unknown indication. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced COUGH (cough), OROPHARYNGEAL PAIN (sore throat) and INFLUENZA (Flu). At the time of the report, COUGH (cough), OROPHARYNGEAL PAIN (sore throat) and INFLUENZA (Flu) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication was High blood pressure med. The treatment medication was unknown.

Other Meds: GABAPENTIN

Current Illness:

ID: 1596456
Sex: F
Age:
State: CA

Vax Date: 03/06/2021
Onset Date: 03/06/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: body ache; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body ache), CHILLS (chills) and HEADACHE (headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced PAIN (body ache), CHILLS (chills) and HEADACHE (headache). At the time of the report, PAIN (body ache), CHILLS (chills) and HEADACHE (headache) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment information was provided. No relevant concomitant medications reported. No medical history was provided by the reporter.

Other Meds:

Current Illness:

ID: 1596457
Sex: F
Age:
State: CA

Vax Date: 03/04/2021
Onset Date: 03/03/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: slight sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (slight sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included IRON and VITAMINS NOS for an unknown indication. On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (slight sore arm). At the time of the report, PAIN IN EXTREMITY (slight sore arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment medications were reported.

Other Meds: IRON; VITAMINS NOS

Current Illness:

ID: 1596458
Sex: F
Age: 61
State: TX

Vax Date: 02/04/2021
Onset Date: 02/04/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm was very sore; hard to lift; felt very unwell; lightheaded; was very cold; very minor soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (very minor soreness at the injection site), PAIN IN EXTREMITY (arm was very sore), LIMB DISCOMFORT (hard to lift), MALAISE (felt very unwell) and DIZZINESS (lightheaded) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced INJECTION SITE PAIN (very minor soreness at the injection site). On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm was very sore), LIMB DISCOMFORT (hard to lift), MALAISE (felt very unwell), DIZZINESS (lightheaded) and NASOPHARYNGITIS (was very cold). At the time of the report, INJECTION SITE PAIN (very minor soreness at the injection site), PAIN IN EXTREMITY (arm was very sore), LIMB DISCOMFORT (hard to lift), MALAISE (felt very unwell), DIZZINESS (lightheaded) and NASOPHARYNGITIS (was very cold) outcome was unknown. Treatment reported include Ibuprofen Motrin 200mg 3 tabs. This case was linked to MOD-2021-035895 (Patient Link).

Other Meds:

Current Illness:

ID: 1596459
Sex: M
Age: 83
State: CA

Vax Date: 02/04/2021
Onset Date: 03/04/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Soreness at the injection site; Fatigue; Headache; A little nausea; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Soreness at the injection site), FATIGUE (Fatigue), HEADACHE (Headache) and NAUSEA (A little nausea) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 013M20A) for COVID-19 vaccination. No Medical History information was reported. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced INJECTION SITE PAIN (Soreness at the injection site), FATIGUE (Fatigue), HEADACHE (Headache) and NAUSEA (A little nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INJECTION SITE PAIN (Soreness at the injection site), FATIGUE (Fatigue), HEADACHE (Headache) and NAUSEA (A little nausea) outcome was unknown. Not Provided No relevant concomitant medications were reported. Action taken with mRNA-1273 in response to the events was not applicable.

Other Meds:

Current Illness:

ID: 1596460
Sex: M
Age: 69
State: MN

Vax Date: 03/04/2021
Onset Date: 03/04/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The patient's past medical history included Cancer (Diagnosed for prostrate cancer 7 years ago and recently got the treatment as "took out small spot on vertebrate". Also reported to finish 5 radiation 2 weeks ago on 19-Feb-2021.). On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications included basic vitamin. The patient also took acupuncture. No treatment was reported.

Other Meds:

Current Illness:

ID: 1596461
Sex: F
Age: 65
State: IL

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: COVID-arm // 1st dose; soreness on arm // 1st dose; redness in the arm // 1st dose; Rash // 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION (COVID-arm // 1st dose), PAIN IN EXTREMITY (soreness on arm // 1st dose), ERYTHEMA (redness in the arm // 1st dose) and INJECTION SITE RASH (Rash // 1st dose) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 011A21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included INFLIXIMAB (REMICADE), AZATHIOPRINE (IMURAN [AZATHIOPRINE]), LISINOPRIL, FISH OIL (FISH OIL OMEGA 3), PANTOPRAZOLE and BUPROPION HYDROCHLORIDE (WELLBUTRIN) for an unknown indication. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (COVID-arm // 1st dose), PAIN IN EXTREMITY (soreness on arm // 1st dose), ERYTHEMA (redness in the arm // 1st dose) and INJECTION SITE RASH (Rash // 1st dose). At the time of the report, TYPE IV HYPERSENSITIVITY REACTION (COVID-arm // 1st dose), PAIN IN EXTREMITY (soreness on arm // 1st dose), ERYTHEMA (redness in the arm // 1st dose) and INJECTION SITE RASH (Rash // 1st dose) outcome was unknown. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. No corrective treatment was provided. This case was linked to MOD-2021-229309 (Patient Link).

Other Meds: REMICADE; IMURAN [AZATHIOPRINE]; LISINOPRIL; FISH OIL OMEGA 3; PANTOPRAZOLE; WELLBUTRIN

Current Illness:

ID: 1596462
Sex: M
Age:
State: PA

Vax Date: 02/28/2021
Onset Date: 03/02/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Lump under armpit (left arm injection site); Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) and LYMPHADENOPATHY (Lump under armpit (left arm injection site)) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. No Medical History information was reported. On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced FATIGUE (Fatigue). On 08-Mar-2021, the patient experienced LYMPHADENOPATHY (Lump under armpit (left arm injection site)). At the time of the report, FATIGUE (Fatigue) and LYMPHADENOPATHY (Lump under armpit (left arm injection site)) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment and concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1596463
Sex: F
Age:
State: IA

Vax Date:
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: bad reaction and went to ER; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (bad reaction and went to ER) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (bad reaction and went to ER). At the time of the report, ADVERSE REACTION (bad reaction and went to ER) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment details included IV. No relevant concomitant medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Non-Significant Follow up received and Contact details were updated.

Other Meds:

Current Illness:

ID: 1596464
Sex: F
Age: 68
State: OH

Vax Date: 03/06/2021
Onset Date: 03/06/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Administered 1ml of the Moderna Covid19 vaccine instead of just 0.5ml; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL OVERDOSE (Administered 1ml of the Moderna Covid19 vaccine instead of just 0.5ml) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No historical condition reported). On 06-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 ml. On 06-Mar-2021, the patient experienced ACCIDENTAL OVERDOSE (Administered 1ml of the Moderna Covid19 vaccine instead of just 0.5ml). On 06-Mar-2021, ACCIDENTAL OVERDOSE (Administered 1ml of the Moderna Covid19 vaccine instead of just 0.5ml) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was provided.; Sender's Comments:

Other Meds:

Current Illness:

ID: 1596465
Sex: F
Age: 78
State: FL

Vax Date: 02/20/2021
Onset Date: 03/01/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vaccination site warmth; Vaccination site erythema; Vaccination site pruritus; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Vaccination site warmth), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE PRURITUS (Vaccination site pruritus) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. No Medical History information was reported. On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Vaccination site warmth), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE PRURITUS (Vaccination site pruritus). At the time of the report, VACCINATION SITE WARMTH (Vaccination site warmth), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE PRURITUS (Vaccination site pruritus) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 559,999

Page last modified: 03 October 2021 5:28pm